• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌腋窝淋巴结分期:我们学到了什么?

Axillary nodal staging in breast cancer: what have we learned?

机构信息

Department of Surgery, Henry Ford Health, Detroit, MI, USA.

出版信息

Clin Exp Metastasis. 2024 Aug;41(4):375-380. doi: 10.1007/s10585-023-10262-2. Epub 2024 Jan 13.

DOI:10.1007/s10585-023-10262-2
PMID:38217839
Abstract

Axillary management in patients with breast cancer is in a constant state of evolution. To provide appropriate treatment recommendations, we must understand the historical implications and the current indications for nodal staging as well as the clinical implications of nodal metastases. As we move away from maximal axillary surgical intervention that was previously the mainstay of breast cancer management, future research efforts will focus on targeted therapies based on tumor biology and identifying oncologically safe methods to de-escalate our management strategies.

摘要

乳腺癌患者的腋窝管理正处于不断发展的状态。为了提供适当的治疗建议,我们必须了解淋巴结分期的历史意义和当前指征,以及淋巴结转移的临床意义。随着我们逐渐摒弃以前乳腺癌治疗的主要手段——最大限度的腋窝手术干预,未来的研究工作将集中在基于肿瘤生物学的靶向治疗上,并确定降低我们管理策略风险的肿瘤学上安全的方法。

相似文献

1
Axillary nodal staging in breast cancer: what have we learned?乳腺癌腋窝淋巴结分期:我们学到了什么?
Clin Exp Metastasis. 2024 Aug;41(4):375-380. doi: 10.1007/s10585-023-10262-2. Epub 2024 Jan 13.
2
[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].[早期浸润性乳腺癌前哨淋巴结活检阳性后腋窝的最佳治疗。OTOASOR试验的早期结果]
Orv Hetil. 2013 Dec 8;154(49):1934-42. doi: 10.1556/OH.2013.29765.
3
Diagnostic accuracy of de-escalated surgical procedure in axilla for node-positive breast cancer patients treated with neoadjuvant systemic therapy: A systematic review and meta-analysis.新辅助系统治疗后腋窝淋巴结阳性乳腺癌患者降阶梯手术的诊断准确性:系统评价和荟萃分析。
Cancer Med. 2022 Nov;11(22):4085-4103. doi: 10.1002/cam4.4769. Epub 2022 May 3.
4
Surgical Management of the Axilla for Breast Cancer.乳腺癌腋窝的外科处理。
Hematol Oncol Clin North Am. 2023 Feb;37(1):51-77. doi: 10.1016/j.hoc.2022.08.005.
5
Imaging-Based Approach to Axillary Lymph Node Staging and Sentinel Lymph Node Biopsy in Patients With Breast Cancer.基于影像学的乳腺癌腋窝淋巴结分期和前哨淋巴结活检方法。
AJR Am J Roentgenol. 2020 Feb;214(2):249-258. doi: 10.2214/AJR.19.22022. Epub 2019 Nov 12.
6
Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer.乳腺癌患者前哨淋巴结免疫组织化学及多层切片评估
Arch Pathol Lab Med. 2003 Jun;127(6):701-5. doi: 10.5858/2003-127-701-EOIAMS.
7
Feasibility of targeted axillary dissection for de-escalation of surgical treatment after neoadjuvant chemotherapy in breast cancer.新辅助化疗后降阶梯手术治疗乳腺癌时行靶向腋窝清扫术的可行性。
Surg Oncol. 2022 Sep;44:101823. doi: 10.1016/j.suronc.2022.101823. Epub 2022 Aug 2.
8
The problem of axillary staging in breast cancer after neoadjuvant chemotherapy. Role of targeted axillary dissection and types of lymph node markers.新辅助化疗后乳腺癌腋窝分期问题。靶向腋窝解剖和淋巴结标志物类型的作用。
Cir Esp (Engl Ed). 2020 Nov;98(9):510-515. doi: 10.1016/j.ciresp.2020.03.012. Epub 2020 May 6.
9
Fine-needle aspiration biopsy of axillary lymph nodes: A reliable diagnostic tool for breast cancer staging.腋窝淋巴结细针穿刺活检:乳腺癌分期的可靠诊断工具。
Cancer Cytopathol. 2024 Feb;132(2):103-108. doi: 10.1002/cncy.22770. Epub 2023 Oct 16.
10
Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.腋窝淋巴结转移对早期乳腺癌患者淋巴绘图及前哨淋巴结识别率的影响
Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):937-42. doi: 10.1007/s00259-005-1797-9. Epub 2005 Apr 19.

引用本文的文献

1
Melanin-Based Nanoparticles for Lymph Node Tattooing: Experimental, Histopathological and Ultrastructural Study.用于淋巴结纹身的黑色素基纳米颗粒:实验、组织病理学和超微结构研究。
Nanomaterials (Basel). 2024 Jul 4;14(13):1149. doi: 10.3390/nano14131149.

本文引用的文献

1
Adjuvant Olaparib for Patients with - or -Mutated Breast Cancer.奥拉帕利辅助治疗 - 或 - 突变型乳腺癌患者。
N Engl J Med. 2021 Jun 24;384(25):2394-2405. doi: 10.1056/NEJMoa2105215. Epub 2021 Jun 3.
2
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.上皮-间质转化的机制新见解及其对癌症的影响。
Nat Rev Mol Cell Biol. 2019 Feb;20(2):69-84. doi: 10.1038/s41580-018-0080-4.
3
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.卡培他滨辅助治疗新辅助化疗后的乳腺癌。
N Engl J Med. 2017 Jun 1;376(22):2147-2159. doi: 10.1056/NEJMoa1612645.
4
Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.新辅助化疗后活检证实淋巴结阳性乳腺癌前哨淋巴结活检:SN FNAC 研究。
J Clin Oncol. 2015 Jan 20;33(3):258-64. doi: 10.1200/JCO.2014.55.7827. Epub 2014 Dec 1.
5
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.新辅助化疗后前哨淋巴结阳性乳腺癌患者的前哨淋巴结手术:ACOSOG Z1071(Alliance)临床试验。
JAMA. 2013 Oct 9;310(14):1455-61. doi: 10.1001/jama.2013.278932.
6
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.新辅助化疗前后乳腺癌前哨淋巴结活检(SENTINA):一项前瞻性、多中心队列研究。
Lancet Oncol. 2013 Jun;14(7):609-18. doi: 10.1016/S1470-2045(13)70166-9. Epub 2013 May 15.
7
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.腋窝清扫与保留腋窝在伴有前哨淋巴结转移的浸润性乳腺癌女性中的随机临床试验
JAMA. 2011 Feb 9;305(6):569-75. doi: 10.1001/jama.2011.90.
8
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.前哨淋巴结切除术与乳腺癌临床淋巴结阴性患者常规腋窝淋巴结清扫术的比较:来自 NSABP B-32 随机 3 期试验的总生存结果。
Lancet Oncol. 2010 Oct;11(10):927-33. doi: 10.1016/S1470-2045(10)70207-2.
9
Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.NSABP B - 32试验对比前哨淋巴结清扫术与腋窝清扫术的结果显示了发病率情况。
J Surg Oncol. 2010 Aug 1;102(2):111-8. doi: 10.1002/jso.21535.
10
The prognosis of carcinoma of the breast in relation to the type of operation performed.乳腺癌的预后与所施行手术类型的关系。
Br J Cancer. 1948 Mar;2(1):7-13. doi: 10.1038/bjc.1948.2.